THE WHAT? Kenvue Brands LLC has updated the product labelling and safety documentation for Neutrogena Oil-Free Acne Stress Control Triple Action Toner, confirming its regulatory classification as an over-the-counter acne treatment.
THE DETAILS The update, dated 15 October 2026, was recorded in the US National Library of Medicine’s DailyMed database. The documentation identifies salicylic acid as the product’s active ingredient and outlines its intended use in managing acne. The filing also provides information on the formulation’s chemical composition, regulatory status and current product labelling. No changes to the formulation or specific new safety concerns were identified in the supplied information.
THE WHY? The update highlights the regulatory requirements governing acne treatment products marketed as over-the-counter medicines in the United States. Maintaining accurate product information and safety documentation is an important compliance obligation for skincare manufacturers operating at the intersection of cosmetics and pharmaceutical regulation.
Source: geneonline
